Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rubitecan in Metastatic Melanoma
NCT00005875Phase 2Completed
- Sponsor
- Astex Pharmaceuticals
- Start
- Jan 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rubitecan in melanoma, sponsored by Astex Pharmaceuticals. Started Jan 1999; status: completed.
02
Drugs
rubitecan
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00005875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005875.